EXEL 34.57 (-5.75%)
US30161Q1040BiotechnologyBiotechnology

Exelixis (EXEL) Financial Metrics

This table shows a selected set of financial data points of Exelixis (EXEL). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2024 1.8018.539.66B0.182.17B633.79M804.08M521.27M217.37M
2023 0.65036.747.63B0.071.83B170.36M196.6M207.77M262.99M
2022 0.56028.565.21B0.061.61B224.16M222.36M182.28M501.2M
2021 0.73024.915.76B0.11.43B336.58M300.3M231.06M647.17M
2020 0.36055.356.19B0.06987.54M178.64M119.2M111.78M319.22M
2019 1.06016.615.33B0.19967.78M514.12M369.47M321.01M266.5M
2018 2.2108.926.15B0.66853.83M382.42M459.86M690.07M314.78M
2017 0.49061.59.48B0.26452.48M144.47M168.44M154.23M183.16M
2016 -0.280-53.193.74B-0.16191.45M204.59M-36.16M-70.22M151.69M
2015 -0.810-6.951.18B-0.5137.17M-142.03M-119.6M-169.74M141.63M
2014 -1.380-1.04279.79M-0.6525.11M-235.88M-217.73M-268.54M80.4M
2013 -1.330-4.611.13B-0.431.34M-200.94M-196.36M-244.76M103.98M
2012 -0.920-4.96731.83M-0.2747.45M-125.86M-114.73M-147.65M170.07M
2011 0.5808.17618.47M0.2289.64M-160.22M100.07M75.7M74.26M
2010 -0.850-9.65890.97M-0.26185.05M-102.86M-72.52M-92.33M97.44M
2009 -1.260-5.84789.13M-0.36151.76M-20.5M-111.24M-135.22M86.8M
2008 -1.540-3.25529.6M-0.4117.86M-24.89M-149.63M-162.85M247.7M
2007 -0.870-9.91855.64M-0.21113.47M-86.14M-75.05M-86.38M135.5M
2006 -1.170-7.68779.42M-0.2898.67M-56.95M-84.58M-101.49M123.4M
2005 -1.070-8.8742.39M-0.2775.96M-60.72M-66.65M-84.4M96.47M
2004 -1.890-5.02688.79M-0.4252.86M-106.17M-119.75M-137.25M78.11M
2003 -1.450-4.86460.98M-0.2751.54M-93.49M-77.37M-94.77M111.83M
2002 -1.520-5.26452.92M-0.2544.32M-36.78M-69.08M-86.13M84.52M
2001 -1.530-10.85772.58M-0.2641.01M-32.86M-55.98M-71.19M35.58M
2000 -2.430-6.03453.83M-0.7424.76M-28.25M-56.45M-75.31M19.55M
1999 -0.44000010.5M-12.3M-13M-18.7M0
1998 -7.8800002.27M0-15.67M-15.67M0

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.

If you accept cookies, we use them to improve and personalize your experience. Manage Cookies